ACS, Acute Coronary Syndrome, Coronary Artery Disease, Myocardial Infarction, Unstable Angina
Conditions
Keywords
Acute coronary syndrome, heart attack, myocardial infarction, ACS long-tem follow up, antithrombotic management, quality of life, Antithrombotic
Brief summary
The aim of this international study is to describe the short- and long-term (i.e. up to 2 years following the index event) antithrombotic management patterns (AMPs) in patients hospitalized for acute coronary syndromes (ST segment elevation myocardial infarction (STEMI), Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS)), and to document the impact of AMPs in clinical outcomes, economic variables and quality of life in a 'real-life' setting and to compare these between sites, countries and regions.
Interventions
None listed
Sponsors
AstraZeneca
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Diagnosis of myocardial infarction or unstable angina * Hospitalized for the first time within 24 hours of onset of symptoms
Exclusion criteria
* Presence of any condition/circumstance which in the opinion of the investigator could significantly limit the complete follow up of the patient (e.g. tourist, non-native speaker or does not understand the local language, psychiatric disturbances) * Current participation in a clinical trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical outcomes (ischemic and bleeding) incidence and time to these clinical outcomes | Longitudinal during 2 years after index event (phone calls to the patients at 6 weeks and each 3 months after index event) |
Secondary
| Measure | Time frame |
|---|---|
| Antithrombotic treatments | Longitudinal during 2 years after index event (phone calls to the patients at 6 weeks and each 3 months after index event) |
| Use of health care resources | Longitudinal during 2 years after index event (phone calls to the patients at 6 weeks and each 3 months after index event) |
| Quality of life | At index event (baseline) and then at 6 weeks and each 3 months after index event |
Countries
Argentina, Belgium, Brazil, Denmark, Finland, France, Germany, Greece, Italy, Luxembourg, Mexico, Netherlands, Norway, Poland, Romania, Slovenia, Spain, Turkey (Türkiye), United Kingdom, Venezuela
Outcome results
None listed